Loading chat...
PA SB461
Bill
Status
3/17/2025
Primary Sponsor
Michele Brooks
Click for details
AI Summary
-
Requires health insurance policies and government programs (Medicaid, CHIP) to cover all diagnostic testing, tick testing, and prescribed treatments for Lyme disease and related tick-borne illnesses when ordered by a health care practitioner
-
Mandates coverage for both short-term and long-term antibiotic or antimicrobial treatments, including oral and intravenous options, based on clinical diagnosis documented in medical records
-
Directs the Department of Health to conduct annual public education campaigns for health care practitioners and provide free educational materials on Lyme disease prevention and treatment
-
Establishes a statewide electronic registry in partnership with East Stroudsburg University's Tick Research Lab to track tick testing results and clinical diagnoses by location
-
Insurers must report to the Insurance Department by January 1, 2027 on implementation; the act takes effect 60 days after enactment with insurance provisions applying to new or renewed policies within 180 days
Legislative Description
Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.
Last Action
Laid on the table (Pursuant to Senate Rule 9)
9/9/2025